We describe an immunocompetent adolescent who presented with exceptionally severe Bordetella holmesii infection, including previously undescribed manifestations. Sequelae included a severe restrictive lung defect due to pulmonary fibrosis.
Only 20 cases of disease caused by Bordetella holmesii, a recently described gram-negative bacillus [1] , have been reported to date [1] [2] [3] [4] [5] . We describe an immunocompetent adolescent who presented with exceptionally severe B. holmesii infection, including previously undescribed manifestations.
A previously healthy 14-year-old girl presented with a 6-month history of weight loss and exertional dyspnoea, and a 3-day history of worsening breathlessness without cough. There was no significant history of contact with ill individuals, travel, drug use, or sexual activity. The patient was thin and afebrile with hepatosplenomagaly, marked respiratory distress, and a large left pleural effusion confirmed by use of a chest radiograph. Neutrophil count was cells/L, lymphocyte On day 7 of hospitalization, a gram-negative bacillus, subsequently identified as B. holmesii [6] , was isolated from cultures of pleural fluid, blood, and lung biopsy specimens. Results of investigations for malignancies and other causes of infection were negative. Bordetella pertussis IgA was initially detected by use of EIA at a low level (ratio to standard serum, 1.39), which subsequently became fully positive (ratio, 1.75). This was ascribed to cross-reaction, because B. holmesii is closely related to B. pertussis [7] . HIV testing was declined, but tests, including a CD4 count, revealed no significant immunodeficiency.
On day 16 of hospitalization, following further deterioration, a second thoracotomy was performed. This revealed a small amount of hemoserous fluid and a "solid" left lung. Spiking fevers continued for 2 weeks, accompanied by persistent respiratory symptoms and splenomegaly. A CT scan of the chest on day 19 showed persistent mediastinal and pericardial fluid. Echocardiography showed a pericardial effusion 8-9 mm in diameter and a thickened pericardium and anterior mitral valve: a diagnosis of endocarditis could not be excluded.
The patient was treated with flucloxacillin (for 13 days), erythromycin (for 11 days), gentamicin (for 20 days) and cefotaxime (for 6 weeks, for possible endocarditis). Her symptoms resolved 1 month after admission and she started to gain weight, reporting that she felt less breathless than she had for the previous 6 months. Six months after discharge, pulmonary function testing continued to indicate that she had a severe restrictive defect. Findings of a CT scan of the chest were consistent with pulmonary fibrosis ( figure 1, bottom) . Echocardiography continued to show a pericardial effusion with pericardial thickening.
We determined the 16S rRNA gene sequence (1427 nucleotide positions) of the B. holmesii strain (99312960) that was isolated from the patient. We found 3 nucleotide differences between this sequence (deposited in the European Molecular Biology Laboratory Nucleotide Sequence Database [EMBL]; ac- cession number AJ239044) and that of B. holmesii strain CDC F5101 (EMBL accession number U04820 [1] ). In all positions where the nucleotide sequence differs, the sequence in strain 99312960 has absolute identity to homologous positions in other Bordetella species, including the 3 B. holmesii-like strains isolated by Tang et al. [3] . Secondary structure predictions of the resultant 16S rRNA molecule suggest conserved structural motifs found in other Bordetella species. The differences in 16S rRNA gene sequences between strains 99312960 and CDC F5101 are not likely to be significant, and strain 99312960 should be classified as B. holmesii.
Previously reported cases of B. holmesii infection have mostly had a relatively acute and uncomplicated course [2] [3] [4] , and most have been associated with underlying disorders [1] [2] [3] . Interstitial and lobar pneumonia with progression to pulmonary fibrosis, pleural effusions, mediastinal collections, pericarditis, hepatosplenomegaly, pancreatitis, lymphopenia, thrombocytopenia, and coagulopathy have not been previously described. This is also the first report of the isolation of this organism from cultures of pleural fluid and lung biopsy specimens. This report documents the most severe and chronic manifestations of B. holmesii infection described to date and broadens the clinical spectrum of disease caused by this emerging pathogen.
